Marinus Pharmaceuticals, Inc. (LON: 0JYL)
London
· Delayed Price · Currency is GBP · Price in USD 0.542
+0.000 (0.04%)
At close: Jan 27, 2025
Marinus Pharmaceuticals Revenue
Marinus Pharmaceuticals had revenue of $8.54M USD in the quarter ending September 30, 2024, with 16.39% growth. This brings the company's revenue in the last twelve months to $31.47M, up 1.63% year-over-year. In the year 2023, Marinus Pharmaceuticals had annual revenue of $30.99M with 21.63% growth.
Revenue (ttm)
$31.47M
Revenue Growth
+1.63%
P/S Ratio
n/a
Revenue / Employee
$189.55K
Employees
166
Market Cap
24.09M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| Shell | 227.10B |
| HSBC Holdings | 43.25B |
| Unilever | 51.12B |
| Rio Tinto Group | 42.87B |
| RELX PLC | 9.30B |
| British American Tobacco p.l.c. | 26.18B |
| BP p.l.c. | 144.69B |